Atherowin-75MG Tab

Tablet

Prevention of atherothrombotic events (heart attack, stroke) in patients with atherosclerosis; after myocardial infarction, ischemic stroke, or established peripheral arterial disease; acute coronary syndrome (with/without stent) usually with aspirin as prescribed.

Clopidogrel is an antiplatelet medicine that irreversibly blocks the platelet P2Y12 (ADP) receptor. This reduces platelet activation and aggregation, helping prevent formation of harmful blood clots in arteries.

Take by mouth as prescribed, usually 75 mg once daily, with or without food. Take at the same time each day; do not stop suddenly without medical advice. If a dose is missed, take it when remembered unless it is close to the next dose; do not double the dose.

Bleeding, easy bruising, nosebleed, gastrointestinal upset, diarrhea, abdominal pain, rash, itching, headache, dizziness

Increases risk of bleeding; seek urgent care for unusual bleeding, black/tarry stools, blood in urine, vomiting blood, or severe headache/weakness. Use caution if you have a bleeding disorder, recent surgery/trauma, peptic ulcer, liver disease, or are elderly. Inform doctor/dentist before any surgery or dental procedure. Rare: thrombotic thrombocytopenic purpura (TTP) and severe allergic reactions—seek immediate care for fever, confusion, jaundice, purple spots, or swelling/breathing difficulty.

Aspirin/other antiplatelets, anticoagulants (warfarin, heparin, DOACs), NSAIDs (ibuprofen, diclofenac), SSRIs/SNRIs (sertraline, fluoxetine, venlafaxine) may increase bleeding risk. PPIs that inhibit CYP2C19 (omeprazole, esomeprazole) may reduce clopidogrel effect; prefer pantoprazole if acid suppression needed. Strong CYP2C19 inhibitors (fluconazole, fluvoxamine) may reduce effect.

Store at room temperature (below 25°C), in original blister pack, protected from moisture and light. Keep out of reach of children.

Clopilet 75 Tablet, Deplatt 75 Tablet, Clopivas 75 Tablet, Plavix 75 Tablet, Clopidogrel 75 mg Tablet (generic)